5-aminosalicylic acid

Related products

• 

  Crohn's disease

  BCG

  【Product name】IMMUCYST, Immunobladder, TICE BCG

  [English common name]Bacillus Calmette-Guerin vaccine

  [Chinese common name]BCG

  [English name]

  [Chinese other name]

  [Indications] This product (BCG immunotherapeutic agent) is suitable for intravesical use and treatment of primary recurrent carcinoma in situ (CIS) of the bladder to reduce the frequency of tumor recurrence. It is indicated for the treatment of carcinoma in situ with or without papillary tumors. However, it is not suitable for the treatment of papilloma that occurs alone. This product is also used as a remedy for the bladder to respond to other in situ carcinoma (CIS) treatments. Treatment and prevention of primary or recurrent carcinoma in situ or superficial papilloma after transurethral resection (TA and T1).

  [Usage and Dosage] Intravesical treatment and prevention of bladder carcinoma in situ (CIS) should be started 7 to 14 days after biopsy or transurethral resection. In a single dose of 3 vials, this product (BCG immunotherapeutic agent) was administered by intravesical injection once a week for 6 weeks (induction therapy). Each dose (3 bottles of prepared vials) was diluted with 50 ml of bacteria and diluted with preservative-free saline to a total of 53 ml. The urethral catheter is inserted into the bladder under aseptic conditions, guiding the contents of the bladder, and then slowly injecting 50 ml of the suspension of the product by gravity, and then taking out the catheter. During the first hour after perfusion, the patient should be placed in the prone, lying down and lying on the left and right sides for 15 minutes. The patient can then stand but maintain the suspension for 60 minutes for a total of 2 hours. It should be taught to urinate if needed for less time. . At the end of the 2 hours, all patients urinate in a sitting position for safety reasons. Patients should be taught to maintain adequate water. The true number of perfusions required to achieve the optimal response is still unknown. Most responding patients are achieved with 6 to 12 perfusions.

  [Storage] The medicine should be placed in a refrigerator of 2 to 8 degrees Celsius (not frozen); if it deteriorates or expires, it can no longer be used.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Psoriatic arthritis (PsA) , Crohn's disease

  Utec monoclonal antibody

  【Product name】Stelara

  [English common name]Ustekinumab

  [Chinese common name]Utec monoclonal antibody

  [English name]

  [Chinese other name]

  [Indications] Stelara is a drug used to treat the following diseases:
  Moderate to severe plaque psoriasis (a disease that causes red, scaly plaque in the skin). It is used in adults and children over the age of 12, and its condition is unresponsive or cannot be treated with other systemic (systemic) psoriasis, such as cyclosporine, methotrexate or PUVA (psoralen UV A). PUVA is a treatment in which a patient receives a drug containing a compound called "psoralen" prior to exposure to ultraviolet light.
  Activity in adultsPsoriatic arthritis(Inflammation of the joints associated with psoriasis), when the condition is not adequately responsive to other treatments, is called anti-rheumatic drugs (DMARDs) that improve the disease. Stelara can be used alone or in combination with methotrexate (DMARD); moderate to severe activity in adultsCrohn's disease(a disease that causes intestinal inflammation), whose condition is poorly responsive to other Crohn's disease treatments or is unacceptable for such treatment.

  [Usage and Dosage] Adults aged 18 years and older started treatment with a loading dose of 320 mg delivered to two 2 ml, subcutaneously 160 mg on the same day at two different locations. Continue to use a weekly injection of 160 mg as a single, 2 ml, subcutaneously administered dose. Don't give ARCALYST more often than once a week. Pediatric patients are 12 to 17 years old: the starting dose for treatment is 4.4 mg/kg, up to 320 mg, delivered with one or two subcutaneous injections, with a maximum single injection volume of 2 mL. Continue to administer a weekly injection of 2.2 mg/kg, up to 160 mg, as a single subcutaneous injection, up to 2 ml. If the initial dose given is two injections, they should be on the same day at two different locations. Don't give ARCALYST more often than once a week.

  [Storage] Store in the refrigerator (2 ° C – 8 ° C). Do not freeze. Keep the vial in an outer carton to prevent light from shining.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Crohn's disease

  Metronidazole

  【Product name】Rozex, Nidazea, Metronidazol, Flagyl, Metronidazole, PYLERA

  [English common name]Metronidazole

  [Chinese common name]Metronidazole

  [English name]2-Methyl-5-nitroimidazole-1-ethanol, 2-(2-methyl-4-nitro-1H-imidazol-1-yl)ethanol

  [Chinese other name]2-methyl-5-nitroimidazole-1-ethanol, 2-(2-methyl-4-nitro-1h-imidazol-1-yl)ethanol

  [indications]
  Compound bismuth potassium citrate metronidazole capsule: for gastric, duodenal ulcer, superficial gastritis, atrophic gastritis and chronic gastritis.
  Metronidazole suppository: This product is used to treat vaginal trichomoniasis.
  Metronidazole injection: This product is mainly used for the treatment of anaerobic infection.
  Artificial bezoar metronidazole capsule: This product is mainly used for acute wisdom tooth pericoronitis, local alveolar abscess, pulpitis, periapical periodontitis and so on.
  Metronidazole chlorhexidine lotion: This product is a compound preparation, containing 1.2 mg of chlorhexidine gluconate and 0.2 mg of metronidazole per ml.

  【Dosage】
  Compound bismuth potassium citrate metronidazole capsule: oral. 1 to 2 capsules each time, once a day.
  Metronidazole suppository: 0.5g once a vaginal administration, once a night 0.5g, for 7 to 10 days, should also take metronidazole tablets, 0.2g each time, four times a day, and even served for seven days.
  Metronidazole injection: intravenous drip.
  1. Commonly used amount of adults: anaerobic infection, intravenous administration for the first time according to body weight of 15mg/kg (70g for adults), maintenance dose of 7.5mg/kg by weight, intravenous infusion every 6-8 hours.
  2. Commonly used in children: The injection dose of anaerobic infection is the same as that of adults.
  Artificial bezoar metronidazole capsule: oral. 2 capsules at a time, 3 times a day.
  Metronidazole chlorhexidine lotion: vaginal rinse. 50 ml once, 2 times a day, 7-10 days for a course of treatment.

  [Storage]
  Compound bismuth potassium citrate metronidazole capsule: sealed, placed in a cool place.
  Metronidazole suppository: shading, sealed, stored in a cool place below 30 °C.
  Metronidazole injection: shading, sealed storage.
  Artificial bezoar metronidazole capsule: shading, confined preservation.
  Metronidazole chlorhexidine lotion: placed in a cool dry place.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Crohn's disease

  Monoclonal antibodies

  【Product name】IILARIS, ADCETRIS, Muromonab

  [English common name]Monoclonal antibody

  [Chinese common name]Monoclonal antibodies

  [English name]

  [Chinese other name]

  [indications]
  Iodine [131I] tumor cell nuclear human mouse chimeric monoclonal antibody injection: for the late stage of radiotherapy and chemotherapy can not control or relapseLung cancerRadioimmunotherapy.
  Recombinant anti-CD25 humanized monoclonal antibody injection: This product is suitable for preventing the occurrence of acute rejection after renal transplantation, and can be combined with an immunosuppressive regimen containing a calmodulin inhibitor and corticosteroids.

  【Dosage】
  Iodine [131I] tumor cell nuclear human mouse chimeric monoclonal antibody injection:
  1. Medication method:
  (1) Systemic administration: This product can be directly bolused, or intravenously established with saline to make a bolus or instillation.
  (2) Topical administration: The drug is injected into the tumor by pulmonary puncture under imaging guidance (CT, fluoroscopy or DSA).
  2. Dosage: Two times per course of treatment, with an interval of 2-4 weeks. The specific dosage is:
  (1) Systemic intravenous injection: The dose is 29.6 MBq (0.8 mCi)/kg.
  (2) Topical administration: Each dose was 18.5-37.0 MBq (0.5-1 mCi)/cm3 of tumor, and the maximum dose was 1850 MBq (50 mCi).
  Recombinant anti-CD25 humanized monoclonal antibody injection: the recommended dose is 1mg/kg, diluted to 50mL of 0.9% sodium chloride injection before use, and then intravenously infused, 15 minutes after the end. The first dose should be administered within 24 hours prior to transplantation, and then administered once every 14 days, twice for a course of treatment. This product can not be directly injected, but should be diluted with 50% of 0.9% sodium chloride injection before intravenous administration. Do not violently oscillate when mixing the solution and gently flip it to prevent foaming. Since this product does not contain any preservatives or bacteriostatic agents, it must be carefully stored to ensure the solution is sterile. This product is a colorless liquid contained in a disposable bottle. Any unused parts after opening should be discarded. Do not dilute and infuse with other drugs in the same solution.

  [Storage]
  Iodine [131I] tumor cell nuclear human mouse chimeric monoclonal antibody injection: sealed, shading, and stored in a dry place.
  Recombinant anti-CD25 humanized monoclonal antibody injection: stored and transported at 2-8 ° C in the dark. Do not freeze or shake vigorously. After dilution, the drug solution can be stored at 2-8 ° C for 24 hours and at room temperature for 4 hours.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.